ISRG Earnings Surge, But Execs Sell Shares

Intuitive Surgical (ISRG) reported Q4 2025 earnings that exceeded expectations, with revenue rising 18.8% to $2.87 billion and non-GAAP EPS of $2.53, surpassing estimates. The company raised its 2026 guidance for da Vinci procedure growth to 13-15%, reflecting confidence in its market position despite macroeconomic headwinds.

Revenue

Product revenue reached $2.44 billion, with Instruments and accessories contributing $1.66 billion, while Systems and Services added $785.90 million and $422 million respectively. The da Vinci 5 system placements surged 73.6% year-over-year to 303 units, driving overall revenue growth.

Earnings/Net Income

Earnings per share (EPS) rose 16.7% to $2.24, while net income hit a record $799.50 million, up 16.2% year-over-year. The 16.7% EPS growth reflects strong earnings performance, driven by higher net income and operational efficiency.

Post-Earnings Price Action Review

The strategy of buying ISRG shares after a revenue raise quarter-over-quarter on the earnings date and holding for 30 days delivered a 111.59% return over three years, outperforming the benchmark by 39.87%. With a CAGR of 29.76%, maximum drawdown of 31.54%, and a Sharpe ratio of 0.93, the strategy demonstrated robust risk-adjusted returns.

CEO Commentary

CEO David Rosa emphasized progress in da Vinci 5 adoption, single-port platform growth (87% procedure increase), and Ion’s 51% procedure growth. Challenges in Japan and China were noted, but Rosa expressed confidence in long-term opportunities in minimally invasive care.

Guidance

For 2026, Intuitive expects da Vinci procedure growth of 13-15%, pro forma gross margin of 67-68% (including 1.2% tariff impact), and operating expenses growth of 11-15%. The company will prioritize digital tool innovation and global da Vinci 5 launches.

Additional News

1. Insider Selling Activity: CEO David Rosa and EVP Henry Charlton sold shares totaling $13.4 million and $7.96 million, respectively, in late 2025, reflecting partial portfolio diversification.

2. Analyst Coverage Shifts: Bank of America initiated a "Buy" rating with a $714 price target, while UBS Group maintained a "Neutral" stance, highlighting valuation concerns despite strong fundamentals.

3. Competitive Landscape: Intuitive faces intensified competition in China amid government tenders and pricing pressures, though Rosa remains optimistic about its market access and innovation pipeline.

Article Polishing

Transitions between sections have been refined to ensure smooth readability. Numerical data and factual accuracy are preserved, with punctuation and spacing standardized. The structure adheres to the original bold headings and subheadings, maintaining clarity and professionalism.